Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 58% ± 24% | |
| oligodendrocyte | 13 studies | 36% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 9821.87 | 2631 / 2642 | 99% | 796.17 | 697 / 705 |
| skin | 0% | 0 | 0 / 1809 | 46% | 21.08 | 218 / 472 |
| kidney | 0% | 0 | 0 / 89 | 18% | 3.71 | 161 / 901 |
| peripheral blood | 10% | 131.74 | 94 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 8% | 1.00 | 6 / 80 |
| lung | 1% | 27.33 | 3 / 578 | 2% | 0.20 | 21 / 1155 |
| thymus | 0% | 1.79 | 1 / 653 | 2% | 1.37 | 13 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.47 | 1 / 45 |
| adrenal gland | 0% | 0 | 0 / 258 | 2% | 0.22 | 5 / 230 |
| breast | 0% | 0 | 0 / 459 | 2% | 0.31 | 17 / 1118 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.09 | 4 / 504 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.29 | 3 / 430 |
| prostate | 0% | 0 | 0 / 245 | 1% | 0.08 | 3 / 502 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.03 | 1 / 178 |
| spleen | 0% | 3.15 | 1 / 241 | 0% | 0 | 0 / 0 |
| uterus | 0% | 0 | 0 / 170 | 0% | 0.01 | 1 / 459 |
| heart | 0% | 1.37 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007423 | Biological process | sensory organ development |
| GO_0014003 | Biological process | oligodendrocyte development |
| GO_0061564 | Biological process | axon development |
| GO_0048663 | Biological process | neuron fate commitment |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0070888 | Molecular function | E-box binding |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | OLIG1 |
| Protein name | Oligodendrocyte transcription factor 1 (Oligo1) (Class B basic helix-loop-helix protein 6) (bHLHb6) (Class E basic helix-loop-helix protein 21) (bHLHe21) Oligodendrocyte transcription factor 1 |
| Synonyms | BHLHE21 BHLHB6 |
| Description | FUNCTION: Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube (By similarity). . |
| Accessions | ENST00000426947.5 ENST00000382348.2 H7C404 Q8TAK6 |